Development of personalized immunotherapy to treat lung cancer using gamma-delta-T cells

开发使用 γ-δ-T 细胞治疗肺癌的个性化免疫疗法

• 批准号: 239690
• 负责人: Zhang Li
• 金额: $ 57.19万
• 依托单位: University Health Network (Toronto)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2011
• 资助国家: 加拿大
• 起止时间: 2011-09-01 至 2016-09-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=239690&lang=en
• 关键词: Adoptive Cellular Therapy; Ex Vivo T Cell Expansion; Gamma-Delta T-Cells; Human; Lung Cancer; Trail

Lung cancer remains the deadliest of cancers despite notable improvements in its treatment, and hence, there is a clear need for new therapies. Treatment of lung cancer will require multi-pronged approaches to be successful. Recently, the concept of cellu

肺癌仍然是最致命的癌症，尽管其治疗有显着的改进，因此，显然需要新的治疗方法。肺癌的治疗需要多管齐下的方法才能取得成功。最近，大提琴的概念